Streetbeat News

Earnings

Adams Resources & Energy (AMEX:AE) is expected to report a Q4 earnings per share (EPS) of $-0.08 on March 13, 2024. Analysts and investors are keen on whether AE will surpass this estimate and provide positive guidance for the next quarter. The company's past earnings performance shows a trend of not meeting EPS estimates, leading to significant share price drops. Currently, AE shares are trading at $25.42, marking a 48.44% decrease over the last 52 weeks, indicating investor concern ahead of the earnings report.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 6:01 pm

PFIE

Profire Energy (NASDAQ:PFIE) is anticipated to report a quarterly EPS of $0.04 on March 13, 2024. Despite a miss in the last quarter with no change in EPS, the stock rose by 3.39% the following day. Historically, Profire Energy has shown positive price changes post-earnings, with shares currently up 29.73% over the last 52 weeks. Investors are keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 6:01 pm

PESI

Perma-Fix Envirn Servs (NASDAQ:PESI) is scheduled to release its quarterly earnings report on March 13, 2024, with an estimated EPS of $0.06. Historical data shows mixed reactions to past earnings, with the stock price fluctuating based on earnings performance and guidance. Over the last year, PESI shares have seen a slight increase of 0.65%.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 6:00 pm

PANL

Pangaea Logistics Solns (NASDAQ:PANL) is set to release its quarterly earnings report on March 13, 2024, with an estimated EPS of $0.34. The company's past performance shows a mix of earnings beats and misses, with a notable 7.63% share price increase following last quarter's earnings beat. Shares are currently trading at $8.27, up 36.69% over the last 52 weeks, indicating a positive outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 6:00 pm

ASAN

Asana Inc (NYSE:ASAN) shares dropped after Q4 results despite upbeat performance. Analysts have mixed views, with DA Davidson and JMP Securities seeing positive aspects, particularly in AI adoption and revenue growth, while RBC Capital Markets and Piper Sandler express concerns over profitability and cash burn. Price targets range from $10 to $27.

Portfolio Pulse from Priya Nigam

March 12, 2024 | 5:38 pm

BODI

ECDA

FEDU

GCT

JZXN

RERE

In Tuesday's intraday session, 12 consumer discretionary stocks saw significant movements. Notable gainers included Jiuzi Holdings, ECD Automotive Design, ATRenew, Four Seasons Education, Beachbody Co, and GigaCloud Tech, with increases ranging from 14.33% to 19.8%. On the downside, Jeffs Brands, Faraday Future, Golden Sun Health, Workhorse Group, Alliance Entertainment, and Dogness (Intl) experienced declines between 10.13% and 33.7%. Earnings reports influenced several of these movements.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:31 pm

CRBU

LEXX

RGLS

VIRX

In Tuesday's intraday session, several healthcare stocks experienced significant movements. Regulus Therapeutics (RGLS) led the gainers with a 94.9% increase, while Lexaria Bioscience (LEXX) saw the largest decline at 30.5%. Other notable movers included Bright Green (BGXX), SCWorx (WORX), and Caribou Biosciences (CRBU), among others. The movements were attributed to various factors, including quarterly earnings reports for Viracta Therapeutics (VIRX) and Caribou Biosciences.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:31 pm

ULCC

Frontier CEO announced in a conference call that the demand for April looks very good, indicating a positive outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 5:22 pm

MSFT

NVDA

ORCL

Oracle Corporation (NYSE:ORCL) experienced a 13% stock value surge following a solid earnings report and a confident outlook, emphasizing 'hypergrowth' in its Gen2 cloud infrastructure business. The company's expansion plans include rapidly opening and expanding cloud datacenters to meet high demand. Analysts have responded positively, with upgrades in ratings and target prices. Oracle's strategic partnerships with Nvidia Corporation (NASDAQ:NVDA) and Microsoft Corporation (NASDAQ:MSFT) further bolster its position in the cloud and AI sectors.

Portfolio Pulse from Neil Dennis

March 12, 2024 | 5:03 pm

QNRX

Quoin Pharmaceuticals (NASDAQ:QNRX) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-2.31. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price following past earnings reports, with the last quarter's beat leading to an 8.26% drop in share price. Currently, shares are trading at $1.14, marking an 81.67% decline over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 5:01 pm